Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
| Available Formats | Price | |
|---|---|---|
ePub eBook
 |
$99.00 | |
| (With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle) | ||
|
Print - Hardback |
$99.00 | |
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
